Internal or External Innovation: Impact of Strategy in Drug Development

NH Riedel - ISPIM Conference Proceedings, 2023 - search.proquest.com
Purpose: The purpose of this paper is to study strategical choices of internal and external
sources of innovation and their impact on innovation success in the pharmaceutical industry …

Accessing external innovation in drug discovery and development

P Tufféry - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: A decline in the productivity of the pharmaceutical industry research and
development (R&D) pipeline has highlighted the need to reconsider the classical strategies …

Supporting radical front end innovation: perceived key factors of pharmaceutical innovation

A Aagaard, F Gertsen - Creativity and Innovation Management, 2011 - Wiley Online Library
This article explores how radical front end innovation is supported in pharmaceutical
companies. The empirical field is an explorative case study of front end innovation in the …

The evolution of research and development in the pharmaceutical industry: toward the open innovation model–can pharma reinvent itself?

R Subramanian, JH Toney… - … Journal of Business …, 2011 - inderscienceonline.com
The global pharmaceutical industry is facing diminishing returns from its massive investment
in research and development. This is particularly troublesome because the industry has long …

The contribution of innovation strategy development and implementation in active facilitation of pharmaceutical front end innovation

A Aagaard - Systemic Practice and Action Research, 2012 - Springer
Front end innovation (FEI) represents the first building blocks of product development, but is
often regarded as a weak link in innovation literature. Various theorists emphasize that a …

[HTML][HTML] External innovation implementation determinants and performance measurement: a case study from the pharmaceutical industry

M Coates, L Bals - 2013 - scirp.org
With an increasing amount of externally sourced innovations, a major success factor for
innovation-dependent indus-tries such as the pharmaceutical industry is to successfully …

Determinants of pharmaceutical innovation in low and middle-income countries: Empirical study conducted in Morocco

I Benali, N Acha, H Barka - Revue management & Innovation, 2021 - cairn.info
As pharmaceutical firms in Low and Middle Income Countries (LMICs) face difficulties
related to Research and Development (R&D) costs, regulation, competition from imported …

Notice of Retraction: Does R&D investment promote firms' performance? Evidence from the pharmaceutical and biological products listed firms

Z Zhaohui, C Xiaokang - 2011 International Conference on …, 2011 - ieeexplore.ieee.org
Notice of Retraction<BR>Does R&amp;D investment promote firms' performance? Evidence
from the pharmaceutical and b Page 1 Notice of Retraction After careful and considered …

Racing to define pharmaceutical R&D external innovation models

L Wang, A Plump, M Ringel - Drug discovery today, 2015 - Elsevier
Highlights•Pharmaceutical R&D is being redefined with a race to identify external innovation
models.•A large diversity of models are being explored, covering the full R&D value …

Key differences and similarities in ways of managing and supporting radical pharmaceutical front end innovation—a case study of the pharmaceutical industry

A Aagaard - International Journal of Innovation Management, 2015 - World Scientific
The purpose of this paper is to explore how Front End Innovation (FEI) is supported and
managed among companies of different nationality within the context of pharmaceutical …